Results 71 to 80 of about 4,584 (134)

Analysis of the regulatory effect of Syk on CD36 antibody-mediated thrombocytopenia

Zhongguo shuxue zazhi
[Objective] To investigate the molecular mechanism of Syk in phagocytosis induced by CD36 antibodies. [Methods] In vitro, two CD36 monoclonal antibodies, GZ1 (IgG2a) and GZ4 (IgG1), at different concentrations were co-incubated with platelets from CD36 ...
REN Hui, CHEN Dawei, LUO Yalin, XIA Wenjie, YE Xin, HE Jiansen, XU Yaori, XU Xiuzhang, FU Yongshui   +8 more
doaj   +1 more source

Antibody-Dependent Cellular Phagocytosis and Cytotoxicity in Patients With LGI1 and CASPR2 Encephalitis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Businaro P, Masciocchi S, Scaranzin S, Morandi C, Zuliani F, Malvaso A, Cerne D, Barone P, Toriello A, Arbasino C, Cenciarelli S, Volonghi I, Casagrande S, Nassani S, Currò-Dossi M, Micheli S, Fattapposta F, Bisecco A, Leone C, Marchioni E, Franciotta D, Spatola M, Zardini E, Benedetti L, Gastaldi M.   +24 more
europepmc   +1 more source

Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200. [PDF]

Front Oncol
Qi S, Deng L, Luo S, Yao Y, Chen T.
europepmc   +1 more source

Beyond Neutralization: Transplant Recipients Display Deficient Antibody-Dependent Cellular Phagocytosis (ADCP) Responses Following SARS-CoV-2 Vaccination

American Journal of Transplantation
A. Ferro, S. Lin, P. Lavoie, V.G. Hall, D. Kumar, A. Humar, V.H. Ferreira   +6 more
openaire   +1 more source

Molecular Profiling of Tisotumab Vedotin-Treated Patients Identifies Immune Pathways Associated with Clinical Activity. [PDF]

Clin Cancer Res
Sridhar S, Roukens MG, Yu CY, Dielen T, van Kessel-Welmers B, Si H, Xu S, Brady LK, Belete M, Bieda M, Shah KN, Aquino R, Gallagher D, Thalhauser CJ, Higgs BW, Fereshteh M, Jure-Kunkel M, Harris JR.   +17 more
europepmc   +1 more source

Catch me if you can! Is there protection from HCV (re)infection? [PDF]

Gut
Bartosch B, Lauer GM.
europepmc   +1 more source

Functional antibody responses and protection against symptomatic dengue. [PDF]

Commun Med (Lond)
Chua CLL, Vo HTM, Victorio CBL, Upasani V, Yap BJM, Teo A.   +5 more
europepmc   +1 more source

Why antibody isotype matters for immunotherapy. [PDF]

Antib Ther
Kleinau S.
europepmc   +1 more source

Protocol for antibody-dependent cellular phagocytosis assay with controlled IgG concentrations in tested samples. [PDF]

STAR Protoc
St Germain R, Sholukh AM.
europepmc   +1 more source

Chronic chikungunya is associated with decreased anti-CHIKV antibody titers, neutralizing capacity, and antibody-dependent cellular cytotoxicity. [PDF]

iScience
Upasani V, Lay S, Heng S, Maestri A, Ken S, Sorn S, Leang R, Ly S, Duong V, Cantaert T.   +9 more
europepmc   +1 more source